DIN 02250519 — ZAVESCA 100 MG
ZAVESCA is a capsule of Miglustat marketed by JANSSEN INC. The full Miglustat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02250519
- Brand name
- ZAVESCA
- Active ingredient
- Miglustat
- Strength
- 100 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Glucosylceramide synthase inhibitor (substrate reduction therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Miglustat products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02556812 | OPFOLDA | 65 MG | CAPSULE | AMICUS THERAPEUTICS CANADA INC. | MARKETED |
| 02456257 | SANDOZ MIGLUSTAT | 100 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |